WebINTRODUCTION. A significant reduction in coronary restenosis rates has been observed with the introduction of drug-eluting stent (DES) technology during percutaneous … WebThe ELUVIA Drug-Eluting Stent is available in a variety of diameters and lengths. The delivery system is also offered in two working lengths (75 cm and 130 cm). 2.2 Drug Component Description The ELUVIA Drug-Eluting Vascular Stent is a stent with a drug/ polymer coating. The coating is comprised of two layers: the
Advantages and disadvantages of biodegradable platforms in drug eluting …
WebThe PROMUS® (2.25 – 4.0 mm) Everolimus-Eluting Coronary Stent System (hereinafter referred to as PROMUS EECSS or PROMUS stent system) is a private-labeled XIENCE V® Everolimus Eluting Coronary Stent System (XIENCE V EECSS or XIENCE V stent system) manufactured by Abbott and distributed by Boston Scientific Corporation. The PROMUS WebSYNERGY Drug-Eluting Stent The SYNERGY Stent is a metal stent with a special drug coating added to help reduce the chance of the artery becoming blocked again. The drug is released from the stent over the period of time during which re-blockage is most likely to occur. The stent was designed to be very flexible, allowing it to fit the shape of your mercy family medicine rogers ar
WALLSTENT™ Endoprosthesis - Boston Scientific
WebStudy Objective: Evaluate the safety and effectiveness of the Promus PtCr EES Coronary Stent System for the treatment of patients with up to 2 de novo lesions ≤ 24 mm in length; ≥ 2.50 mm to ≤ 4.25 mm in diameter compared to the Xience CoCr EES. Study Design: Prospective, Randomized, Controlled, Non-inferiority, Multicenter. WebDrug-eluting stent: a review and update ... noncomplex lesion is the TaxusTM stent (Boston Scientific, Natrick, MA, USA), of native coronary arteries. The RAVEL study … WebThe objective of this study is to compare the outcomes of patients treated with drug-coated balloons (DCBs) or second-generation drug-eluting stents (DESs) for de novo unprotected left main stem (LMS) disease. Previous studies comparing the treatment of LMS disease suggest that the mortality for DES PCI is not worse than CABG. There are limited data … how old is nardwuar